Archer Aviation Inc vs Novartis AG — how do they compare? Archer Aviation Inc trades at $6.82 (market cap $5.23B), while Novartis AG trades at $152.33 (market cap $295.37B). The key difference: Novartis AG is far larger — about 56.5× Archer Aviation Inc's market cap, and Novartis AG pays a 3.07% dividend while Archer Aviation Inc pays none. Which is the better fit depends on your goals.
| ACHR | NVS | |
|---|---|---|
Market Cap | $5.23B | $295.37B |
Sector | Industrials | Health |
52-Week High | $13.64 | $168.62 |
52-Week Low | $4.44 | $119.31 |
Enterprise Value | $3.79B | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Archer Aviation develops electric vertical takeoff and landing (eVTOL) aircraft for urban air mobility. Its flagship, Midnight aircraft, is designed for air taxi services, aiming to transform urban travel with sustainable aviation.
Read more on ACHR →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →